Elsevier MDL Release: MDL Isentris Platform Selected By LEO Pharma

SAN LEANDRO, Calif.--(BUSINESS WIRE)--Dec. 21, 2005--Elsevier MDL is pleased to announce that LEO Pharma, one of Denmark’s leading research-based pharmaceutical companies, has selected the complete MDL(R) Isentris(R) information management and integration platform for its R&D operations. As the first open-standards-based, n-tier discovery informatics platform specifically designed for life sciences researchers, Isentris is unique in effectively integrating the data and workflow applications scientists use every day and promoting a self-service research environment to enhance decision making and improve R&D productivity.

MORE ON THIS TOPIC